[1] WHO. Global tuberculosis report 2021. WHO. 2021.
[2] Dong Z, Yao HY, Yu SC, et al. Changes in notified incidence of pulmonary tuberculosis in China, 2005-2020. Biomed Environ Sci, 2023; 36, 117−26.
[3] Li XX, Wang LX, Zhang H, et al. Spatial variations of pulmonary tuberculosis prevalence co-impacted by socio-economic and geographic factors in People's Republic of China, 2010. BMC Public Health, 2014; 14, 257. doi:  10.1186/1471-2458-14-257
[4] Wubuli A, Xue F, Jiang DB, et al. Socio-demographic predictors and distribution of pulmonary tuberculosis (TB) in Xinjiang, China: a spatial analysis. PLoS One, 2015; 10, e0144010. doi:  10.1371/journal.pone.0144010
[5] Mijiti P, Li YH, Xue F, et al. Prevalence of pulmonary tuberculosis in western China in 2010–11: a population-based, cross-sectional survey. Lancet Global Health, 2016; 4, e485−94. doi:  10.1016/S2214-109X(16)30074-2
[6] He XY, Cao MQ, Mahapatra T, et al. Burden of tuberculosis in Xinjiang between 2011 and 2015: A surveillance data-based study. PLoS One, 2017; 12, e0187592. doi:  10.1371/journal.pone.0187592
[7] Liu MY, Li QH, Zhang YJ, et al. Spatial and temporal clustering analysis of tuberculosis in the mainland of China at the prefecture level, 2005-2015. Infect Dis Poverty, 2018; 7, 106. doi:  10.1186/s40249-018-0490-8
[8] Yates TA, Khan PY, Knight GM, et al. The transmission of Mycobacterium tuberculosis in high burden settings. Lancet Infect Dis, 2016; 16, 227−38. doi:  10.1016/S1473-3099(15)00499-5
[9] Shah NS, Auld SC, Brust JCM, et al. Transmission of extensively drug-resistant tuberculosis in south Africa. N Engl J Med, 2017; 376, 243−53. doi:  10.1056/NEJMoa1604544
[10] Kendall EA, Fofana MO, Dowdy DW. Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis. Lancet Respir Med, 2015; 3, 963−72. doi:  10.1016/S2213-2600(15)00458-0
[11] Koch A, Cox H. Preventing drug-resistant tuberculosis transmission. Lancet Infect Dis, 2020; 20, 157−8. doi:  10.1016/S1473-3099(19)30613-9
[12] Cancino-Muñoz I, López MG, Torres-Puente M, et al. Population-based sequencing of Mycobacterium tuberculosis reveals how current population dynamics are shaped by past epidemics. eLife, 2022; 11, e76605. doi:  10.7554/eLife.76605
[13] Small PM, Hopewell PC, Singh SP, et al. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med, 1994; 330, 1703−9. doi:  10.1056/NEJM199406163302402
[14] Kato-Maeda M, Small PM. How molecular epidemiology has changed what we know about tuberculosis. West J Med, 2000; 172, 256−9. doi:  10.1136/ewjm.172.4.256
[15] Frieden TR, Sherman LF, Maw KL, et al. A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes. JAMA, 1996; 276, 1229−35. doi:  10.1001/jama.1996.03540150031027
[16] Tabet SR, Goldbaum GM, Hooton TM, et al. Restriction fragment length polymorphism analysis detecting a community-based tuberculosis outbreak among persons infected with human immunodeficiency virus. J Infect Dis, 1994; 169, 189−92. doi:  10.1093/infdis/169.1.189
[17] The Ministry of Health,China Center for Disease Control and Prevention. Guidelines for the implementation of China's tuberculosis control program. Beijing: China Peking Union Medical College Press, 2008. (In Chinese
[18] Schiebelhut LM, Abboud SS, Gómez Daglio LE, et al. A comparison of DNA extraction methods for high-throughput DNA analyses. Mol Ecol Resour, 2017; 17, 721−9.
[19] Liu QY, Ma AJ, Wei LH, et al. China's tuberculosis epidemic stems from historical expansion of four strains of Mycobacterium tuberculosis. Nat Ecol Evol, 2018; 2, 1982−92. doi:  10.1038/s41559-018-0680-6
[20] Chen YW, Liu QY, Takiff HE, et al. Comprehensive genomic analysis of Mycobacterium tuberculosis reveals limited impact of high-fitness genotypes on MDR-TB transmission. J Infect, 2022; 85, 49−56. doi:  10.1016/j.jinf.2022.05.012
[21] Liu CF, Song YM, He P, et al. Evaluation of multidrug resistant loop-mediated isothermal amplification assay for detecting the drug resistance of Mycobacterium tuberculosis. Biomed Environ Sci, 2021; 34, 616−22.
[22] Yang TT, Gan MY, Liu QY, et al. SAM-TB: a whole genome sequencing data analysis website for detection of Mycobacterium tuberculosis drug resistance and transmission. Brief Bioinform, 2022; 23, bbac030. doi:  10.1093/bib/bbac030
[23] Li M, Guo MC, Peng Y, et al. High proportion of tuberculosis transmission among social contacts in rural China: a 12-year prospective population-based genomic epidemiological study. Emerg Microbes Infect, 2022; 11, 2102−11. doi:  10.1080/22221751.2022.2112912
[24] Jiang Q, Liu QY, Ji LC, et al. Citywide transmission of multidrug-resistant tuberculosis under China's rapid urbanization: a retrospective population-based genomic spatial epidemiological study. Clin Infect Dis, 2020; 71, 142−51. doi:  10.1093/cid/ciz790
[25] Coll F, McNerney R, Guerra-Assunção JA, et al. A robust SNP barcode for typing Mycobacterium tuberculosis complex strains. Nat Commun, 2014; 5, 4812. doi:  10.1038/ncomms5812
[26] Kumar S, Stecher G, Li M, et al. MEGA X: Molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol, 2018; 35, 1547−9. doi:  10.1093/molbev/msy096
[27] Casali N, Nikolayevskyy V, Balabanova Y, et al. Evolution and transmission of drug-resistant tuberculosis in a Russian population. Nat Genet, 2014; 46, 279−86. doi:  10.1038/ng.2878
[28] Yang CG, Luo T, Shen X, et al. Transmission of multidrug-resistant Mycobacterium tuberculosis in Shanghai, China: a retrospective observational study using whole-genome sequencing and epidemiological investigation. Lancet Infect Dis, 2017; 17, 275−84. doi:  10.1016/S1473-3099(16)30418-2
[29] Technical Guidance Group of the Fifth National TB Epidemiological Survey, The Office of the Fifth National TB Epidemiological Survey. The fifth national tuberculosis epidemiological survey in 2010. Chin J Antituberc, 2012; 34, 485−508. (In Chinese
[30] Maiweilanjiang·Abulimiti, Diermulati·Tusun, Liu ZJ, et al. Analysis on the therapeutic effect and influencing factors of initial treated smear-positive pulmonary tuberculosis patients in Kashgar Prefecture from 2016 to 2018. Chin J Antituberc, 2021; 43, 391−7. (In Chinese
[31] Raviglione MC, Uplekar MW. WHO's new stop TB strategy. Lancet, 2006; 367, 952−5. doi:  10.1016/S0140-6736(06)68392-X
[32] Wang SF, Zhou Y, Ou XC, et al. Prevalence of drug resistant tuberculosis in China: data from national drug resistant tuberculosis survey in 2018. Chin J Antituberc, 2022; 44, 1141−7. (In Chinese
[33] Colangeli R, Gupta A, Vinhas SA, et al. Mycobacterium tuberculosis progresses through two phases of latent infection in humans. Nat Commun, 2020; 11, 4870. doi:  10.1038/s41467-020-18699-9
[34] Behr MA, Edelstein PH, Ramakrishnan L. Revisiting the timetable of tuberculosis. BMJ, 2018; 362, k2738.
[35] Walker TM, Lalor MK, Broda A, et al. Assessment of Mycobacterium tuberculosis transmission in Oxfordshire, UK, 2007-12, with whole pathogen genome sequences: an observational study. Lancet Respir Med, 2014; 2, 285−92. doi:  10.1016/S2213-2600(14)70027-X
[36] Guerra-Assunção JA, Crampin AC, Houben RMGJ, et al. Large-scale whole genome sequencing of M. tuberculosis provides insights into transmission in a high prevalence area. eLife, 2015; 4, e05166. doi:  10.7554/eLife.05166
[37] Liu M, Xu P, Liao XW, et al. Molecular epidemiology and drug-resistance of tuberculosis in Luodian revealed by whole genome sequencing. Infect Genet Evol, 2021; 93, 104979. doi:  10.1016/j.meegid.2021.104979
[38] Wang M, Zhang YY, Huang C, et al. A whole-genome sequencing-based study to delineate the risk and characteristics of tuberculosis transmission in an insular population over 10 years in Shanghai. Front Microbiol, 2021; 12, 768659.
[39] Yang TT, Wang YX, Liu QY, et al. A population-based genomic epidemiological study of the source of tuberculosis infections in an emerging city: Shenzhen, China. Lancet Reg Health West Pac, 2021; 8, 100106. doi:  10.1016/j.lanwpc.2021.100106
[40] Nava-Aguilera E, Andersson N, Harris E, et al. Risk factors associated with recent transmission of tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis, 2009; 13, 17−26.
[41] Yuen CM, Kammerer JS, Marks K, et al. Recent transmission of tuberculosis - United States, 2011-2014. PLoS One, 2016; 11, e0153728. doi:  10.1371/journal.pone.0153728
[42] Melnyk AH, Wong A, Kassen R. The fitness costs of antibiotic resistance mutations. Evol Appl, 2015; 8, 273−83. doi:  10.1111/eva.12196
[43] Becerra MC, Huang CC, Lecca L, et al. Transmissibility and potential for disease progression of drug resistant Mycobacterium tuberculosis: prospective cohort study. BMJ, 2019; 367, l5894.
[44] Theron G, Limberis J, Venter R, et al. Bacterial and host determinants of cough aerosol culture positivity in patients with drug-resistant versus drug-susceptible tuberculosis. Nat Med, 2020; 26, 1435−43. doi:  10.1038/s41591-020-0940-2
[45] Jones-López EC, Namugga O, Mumbowa F, et al. Cough aerosols of Mycobacterium tuberculosis predict new infection. a household contact study. Am J Respir Crit Care Med, 2013; 187, 1007−15. doi:  10.1164/rccm.201208-1422OC
[46] Yang EZ, Yang R, Guo M, et al. Multidrug-resistant tuberculosis (MDR-TB) strain infection in macaques results in high bacilli burdens in airways, driving broad innate/adaptive immune responses. Emerg Microbes Infect, 2018; 7, 1−12.
[47] Mathema B, Andrews JR, Cohen T, et al. Drivers of tuberculosis transmission. J Infect Dis, 2017; 216, S644−53. doi:  10.1093/infdis/jix354
[48] van Soolingen D, Borgdorff MW, de Haas PEW, et al. Molecular epidemiology of tuberculosis in the Netherlands: a nationwide study from 1993 through 1997. J Infect Dis, 1999; 180, 726−36. doi:  10.1086/314930
[49] Burgos M, DeRiemer K, Small PM, et al. Effect of drug resistance on the generation of secondary cases of tuberculosis. J Infect Dis, 2003; 188, 1878−84. doi:  10.1086/379895
[50] Yang CG, Shen X, Peng Y, et al. Transmission of Mycobacterium tuberculosis in China: a population-based molecular epidemiologic study. Clin Infect Dis, 2015; 61, 219−27. doi:  10.1093/cid/civ255
[51] Cowley D, Govender D, February B, et al. Recent and rapid emergence of W-Beijing strains of Mycobacterium tuberculosis in Cape Town, South Africa. Clin Infect Dis, 2008; 47, 1252−9. doi:  10.1086/592575
[52] Niemann S, Merker M, Kohl T, et al. Impact of genetic diversity on the biology of Mycobacterium tuberculosis complex strains. Microbiol Spectr, 2016; 4.
[53] Tsenova L, Ellison E, Harbacheuski R, et al. Virulence of selected Mycobacterium tuberculosis clinical isolates in the rabbit model of meningitis is dependent on phenolic glycolipid produced by the bacilli. J Infect Dis, 2005; 192, 98−106. doi:  10.1086/430614
[54] Parwati I, van Crevel R, van Soolingen D. Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains. Lancet Infect Dis, 2010; 10, 103−11. doi:  10.1016/S1473-3099(09)70330-5
[55] Manca C, Reed MB, Freeman S, et al. Differential monocyte activation underlies strain-specific Mycobacterium tuberculosis pathogenesis. Infect Immun, 2004; 72, 5511−4. doi:  10.1128/IAI.72.9.5511-5514.2004
[56] Kerubo G, Ndungu P, Shuaib YA, et al. Molecular epidemiology of Mycobacterium tuberculosis complex strains in urban and slum settings of Nairobi, Kenya. Genes, 2022; 13, 475. doi:  10.3390/genes13030475
[57] O'Neill MB, Shockey A, Zarley A, et al. Lineage specific histories of Mycobacterium tuberculosis dispersal in Africa and Eurasia. Mol Ecol, 2019; 28, 3241−56. doi:  10.1111/mec.15120
[58] Jia QJ, Zeng MC, Cheng QL, et al. The retrospective diagnostic potential of GeneXpert MTB/RIF for the analysis of formalin-fixed paraffin-embedded tissue from extrapulmonary tuberculosis patients. Biomed Environ Sci, 2023; 36, 295−8.